Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis

BACKGROUND: Currently, there are many therapeutic methods for lung adenocarcinoma (LUAD), but the 5-year survival rate is still only 15% at later stages. Epithelial– mesenchymal transition (EMT) has been shown to be closely associated with local dissemination and subsequent metastasis of solid tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, De-Hua, Du, Qian-Cheng, Fu, Zheng, Wang, Xin-Yu, Zhou, Ling, Wang, Jian, Hu, Cheng-Kai, Liu, Shun, Li, Jun-Min, Ma, Meng-Li, Yu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477694/
https://www.ncbi.nlm.nih.gov/pubmed/36159424
http://dx.doi.org/10.12998/wjcc.v10.i26.9285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477694/
https://www.ncbi.nlm.nih.gov/pubmed/36159424
http://dx.doi.org/10.12998/wjcc.v10.i26.9285

Ejemplares similares